Zoetis Capital Stock vs Deferred Long Term Liab Analysis

ZTS Stock

USD 174.06 0.35 0.20%

Zoetis financial indicator trend analysis is more than just analyzing Zoetis Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zoetis Inc is a good investment. Please check the relationship between Zoetis Capital Stock and its Deferred Long Term Liab accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Capital Stock vs Deferred Long Term Liab

Capital Stock vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zoetis Inc Capital Stock account and Deferred Long Term Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Zoetis' Capital Stock and Deferred Long Term Liab is -0.09. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Zoetis Inc, assuming nothing else is changed. The correlation between historical values of Zoetis' Capital Stock and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Zoetis Inc are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Capital Stock i.e., Zoetis' Capital Stock and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

-0.09

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Zoetis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zoetis Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Sales General And Administrative To Revenue is likely to gain to 0.29 in 2024, whereas Selling General Administrative is likely to drop slightly above 1.3 B in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	224M	221M	285M	162.4M
Depreciation And Amortization	161M	150M	491M	515.6M

Interest Expense Depreciation And Amortization

Zoetis fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		-0.39	-0.25	-0.6	-0.29	-0.41	-0.22	-0.43	0.32	-0.18	-0.2	-0.29	-0.41	-0.41	-0.31	-0.23	-0.29	-0.4	-0.37	-0.25	-0.37	-0.43	0.63	-0.27	-0.78	-0.35
Total Assets	-0.39		0.9	0.49	0.82	0.56	0.76	0.94	-0.07	0.73	0.6	0.94	0.98	0.49	0.58	0.87	0.94	0.78	0.97	0.88	0.85	0.96	-0.86	0.92	0.75	0.98
Short Long Term Debt Total	-0.25	0.9		0.33	0.78	0.16	0.82	0.77	0.08	0.93	0.57	0.88	0.87	0.22	0.27	0.99	0.88	0.75	0.9	0.99	0.72	0.8	-0.86	1.0	0.57	0.89
Other Current Liab	-0.6	0.49	0.33		0.32	0.5	0.18	0.56	-0.85	0.26	0.31	0.35	0.47	0.6	0.32	0.34	0.35	0.59	0.42	0.33	0.67	0.54	-0.61	0.35	0.79	0.48
Total Current Liabilities	-0.29	0.82	0.78	0.32		0.4	0.44	0.78	0.11	0.61	0.62	0.83	0.75	0.28	0.52	0.68	0.83	0.7	0.74	0.68	0.77	0.72	-0.72	0.79	0.64	0.87
Total Stockholder Equity	-0.41	0.56	0.16	0.5	0.4		0.16	0.69	-0.33	-0.11	0.23	0.46	0.58	0.73	0.81	0.1	0.45	0.32	0.51	0.13	0.56	0.65	-0.31	0.19	0.62	0.52
Other Liab	-0.22	0.76	0.82	0.18	0.44	0.16		0.55	0.1	0.76	0.24	0.72	0.8	0.12	0.19	0.84	0.73	0.43	0.85	0.86	0.43	0.65	-0.62	0.82	0.34	0.67
Property Plant And Equipment Net	-0.43	0.94	0.77	0.56	0.78	0.69	0.55		-0.17	0.61	0.58	0.81	0.92	0.7	0.67	0.73	0.81	0.83	0.87	0.74	0.93	0.97	-0.84	0.79	0.83	0.91
Current Deferred Revenue	0.32	-0.07	0.08	-0.85	0.11	-0.33	0.1	-0.17		0.09	0.01	0.05	-0.09	-0.47	-0.09	0.04	0.05	-0.21	-0.04	0.05	-0.29	-0.14	0.17	0.07	-0.4	-0.06
Net Debt	-0.18	0.73	0.93	0.26	0.61	-0.11	0.76	0.61	0.09		0.43	0.64	0.73	0.18	0.03	0.94	0.65	0.71	0.76	0.93	0.61	0.64	-0.81	0.91	0.44	0.69
Accounts Payable	-0.2	0.6	0.57	0.31	0.62	0.23	0.24	0.58	0.01	0.43		0.62	0.5	0.16	0.4	0.56	0.62	0.75	0.49	0.56	0.57	0.62	-0.57	0.6	0.49	0.67
Cash	-0.29	0.94	0.88	0.35	0.83	0.46	0.72	0.81	0.05	0.64	0.62		0.86	0.23	0.5	0.84	1.0	0.65	0.88	0.85	0.71	0.85	-0.75	0.89	0.61	0.97
Non Current Assets Total	-0.41	0.98	0.87	0.47	0.75	0.58	0.8	0.92	-0.09	0.73	0.5	0.86		0.55	0.56	0.85	0.87	0.74	0.99	0.86	0.8	0.95	-0.83	0.89	0.72	0.91
Non Currrent Assets Other	-0.41	0.49	0.22	0.6	0.28	0.73	0.12	0.7	-0.47	0.18	0.16	0.23	0.55		0.68	0.21	0.23	0.51	0.45	0.22	0.68	0.61	-0.48	0.24	0.65	0.4
Other Assets	-0.31	0.58	0.27	0.32	0.52	0.81	0.19	0.67	-0.09	0.03	0.4	0.5	0.56	0.68		0.2	0.5	0.35	0.49	0.22	0.61	0.64	-0.35	0.3	0.51	0.56
Long Term Debt	-0.23	0.87	0.99	0.34	0.68	0.1	0.84	0.73	0.04	0.94	0.56	0.84	0.85	0.21	0.2		0.85	0.75	0.88	1.0	0.69	0.79	-0.86	0.99	0.54	0.86
Cash And Short Term Investments	-0.29	0.94	0.88	0.35	0.83	0.45	0.73	0.81	0.05	0.65	0.62	1.0	0.87	0.23	0.5	0.85		0.65	0.89	0.86	0.71	0.85	-0.75	0.9	0.61	0.97
Net Receivables	-0.4	0.78	0.75	0.59	0.7	0.32	0.43	0.83	-0.21	0.71	0.75	0.65	0.74	0.51	0.35	0.75	0.65		0.7	0.74	0.84	0.8	-0.87	0.77	0.78	0.79
Good Will	-0.37	0.97	0.9	0.42	0.74	0.51	0.85	0.87	-0.04	0.76	0.49	0.88	0.99	0.45	0.49	0.88	0.89	0.7		0.9	0.75	0.92	-0.81	0.91	0.66	0.9
Non Current Liabilities Total	-0.25	0.88	0.99	0.33	0.68	0.13	0.86	0.74	0.05	0.93	0.56	0.85	0.86	0.22	0.22	1.0	0.86	0.74	0.9		0.69	0.8	-0.85	0.99	0.54	0.86
Inventory	-0.37	0.85	0.72	0.67	0.77	0.56	0.43	0.93	-0.29	0.61	0.57	0.71	0.8	0.68	0.61	0.69	0.71	0.84	0.75	0.69		0.87	-0.84	0.74	0.84	0.86
Other Current Assets	-0.43	0.96	0.8	0.54	0.72	0.65	0.65	0.97	-0.14	0.64	0.62	0.85	0.95	0.61	0.64	0.79	0.85	0.8	0.92	0.8	0.87		-0.84	0.83	0.8	0.92
Other Stockholder Equity	0.63	-0.86	-0.86	-0.61	-0.72	-0.31	-0.62	-0.84	0.17	-0.81	-0.57	-0.75	-0.83	-0.48	-0.35	-0.86	-0.75	-0.87	-0.81	-0.85	-0.84	-0.84		-0.87	-0.87	-0.84
Total Liab	-0.27	0.92	1.0	0.35	0.79	0.19	0.82	0.79	0.07	0.91	0.6	0.89	0.89	0.24	0.3	0.99	0.9	0.77	0.91	0.99	0.74	0.83	-0.87		0.59	0.91
Property Plant And Equipment Gross	-0.78	0.75	0.57	0.79	0.64	0.62	0.34	0.83	-0.4	0.44	0.49	0.61	0.72	0.65	0.51	0.54	0.61	0.78	0.66	0.54	0.84	0.8	-0.87	0.59		0.74
Total Current Assets	-0.35	0.98	0.89	0.48	0.87	0.52	0.67	0.91	-0.06	0.69	0.67	0.97	0.91	0.4	0.56	0.86	0.97	0.79	0.9	0.86	0.86	0.92	-0.84	0.91	0.74

Click cells to compare fundamentals

Zoetis Account Relationship Matchups

Zoetis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.5B	13.6B	13.9B	14.9B	14.3B	10.5B
Short Long Term Debt Total	6.6B	7.4B	6.7B	8.1B	6.8B	5.1B
Other Current Liab	55M	93M	1.3B	1.4B	1.4B	1.5B
Total Current Liabilities	1.8B	2.2B	1.8B	3.2B	1.9B	1.7B
Total Stockholder Equity	2.7B	3.8B	4.5B	4.4B	5.0B	3.2B
Other Liab	917M	891M	811M	585M	672.8M	614.3M
Property Plant And Equipment Net	2.1B	2.4B	2.6B	3.0B	3.4B	2.0B
Current Deferred Revenue	950M	1.0B	6M	5M	4.5M	4.3M
Net Debt	4.7B	3.8B	3.3B	4.5B	4.8B	3.4B
Accounts Payable	301M	457M	436M	405M	411M	367.5M
Cash	1.9B	3.6B	3.5B	3.6B	2.0B	1.7B
Non Current Assets Total	6.8B	7.0B	7.0B	7.4B	7.9B	5.6B
Other Assets	160M	392M	211M	320M	368M	222.8M
Long Term Debt	5.9B	6.6B	6.6B	6.6B	6.6B	4.8B
Cash And Short Term Investments	1.9B	3.6B	3.5B	3.6B	2.0B	1.7B
Net Receivables	1.1B	1.0B	1.1B	1.2B	1.3B	1.1B
Good Will	2.6B	2.7B	2.7B	2.7B	2.8B	2.0B
Liabilities And Stockholders Equity	11.5B	13.6B	13.9B	14.9B	14.3B	10.5B
Non Current Liabilities Total	7.0B	7.7B	7.6B	7.4B	7.4B	5.6B
Inventory	1.4B	1.6B	1.9B	2.3B	2.6B	1.7B
Other Current Assets	318M	366M	389M	365M	434M	301.3M
Other Stockholder Equity	(998M)	(1.2B)	(1.9B)	(3.5B)	(4.5B)	(4.2B)
Total Liab	8.8B	9.8B	9.4B	10.5B	9.3B	7.3B
Property Plant And Equipment Gross	2.1B	2.2B	4.7B	5.3B	6.0B	6.3B
Total Current Assets	4.7B	6.6B	6.9B	7.5B	6.3B	4.9B
Accumulated Other Comprehensive Income	(726M)	(730M)	(764M)	(817M)	(839M)	(797.1M)
Short Term Debt	500M	604M	41M	1.4B	51M	48.5M
Intangible Assets	1.9B	1.7B	1.5B	1.4B	1.3B	1.4B
Property Plant Equipment	1.9B	2.2B	2.4B	2.8B	3.2B	1.8B
Retained Earnings	4.4B	5.7B	7.2B	8.7B	10.3B	10.8B
Retained Earnings Total Equity	4.4B	5.7B	7.2B	8.7B	10.0B	10.5B
Deferred Long Term Liab	434M	378M	320M	142M	163.3M	290.0M
Treasury Stock	(2.0B)	(2.2B)	(3.0B)	(4.5B)	(4.1B)	(3.9B)
Net Tangible Assets	(1.8B)	(635M)	387M	279M	320.9M	336.9M

Pair Trading with Zoetis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zoetis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zoetis will appreciate offsetting losses from the drop in the long position's value.

Moving together with Zoetis Stock

0.61	EQ	Equillium Earnings Call This Week	Pair Corr
0.7	KA	Kineta Inc	Pair Corr
0.67	ME	23Andme Holding	Pair Corr

Moving against Zoetis Stock

0.75	YS	YS Biopharma	Pair Corr
0.75	DOMH	Dominari Holdings	Pair Corr
0.45	VALN	Valneva SE ADR	Pair Corr

The ability to find closely correlated positions to Zoetis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zoetis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zoetis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zoetis Inc to buy it.

The correlation of Zoetis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zoetis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zoetis Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Zoetis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:

How To Invest In Zoetis

Details

Is Zoetis Stock a good investment?

Details

What is Zoetis' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Zoetis Stock analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes

Is Zoetis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zoetis. If investors know Zoetis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.099

Dividend Share

1.557

Earnings Share

5.19

Revenue Per Share

18.995

Quarterly Revenue Growth

0.095

The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zoetis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zoetis Capital Stock vs Deferred Long Term Liab Analysis

Capital Stock vs Deferred Long Term Liab

Capital Stock vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Capital Stock

Deferred Long Term Liab

Zoetis fundamental ratios Correlations

Zoetis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zoetis fundamental ratios Accounts

Pair Trading with Zoetis

Moving together with Zoetis Stock

Moving against Zoetis Stock

Complementary Tools for Zoetis Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 1.0	Long Term Debt
Long Term Debt	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Good Will	+ 0.99	Non Current Assets Total

Property Plant And Equipment Gross	- 0.87	Other Stockholder Equity
Total Liab	- 0.87	Other Stockholder Equity
Other Stockholder Equity	- 0.87	Net Receivables
Other Stockholder Equity	- 0.86	Long Term Debt
Other Stockholder Equity	- 0.86	Short Long Term Debt Total
Other Stockholder Equity	- 0.86	Total Assets